BIEI - Premier Biomedical, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.20
0.00 (0.00%)
At close: 1:55PM EDT
Stock chart is not supported by your current browser
Previous Close0.20
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume1,821,326
Market Cap597,846
Beta-1.37
PE Ratio (TTM)0.55
EPS (TTM)0.36
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • ACCESSWIREyesterday

    PainReliefMeds.com Resumes Credit Card Processing

    Issues Related to the Suspension of Credit Card Processing Have Been Resolved JACKSON CENTER, PA / ACCESSWIRE / August 15, 2018 / PainReliefMeds.com , the website which sells the topical pain relief treatments ...

  • ACCESSWIRE9 days ago

    Premier Biomedical Signs Agreement With Sales Group to Represent Premier's Topical Pain Relief Products to the Military

    JACKSON CENTER, PA / ACCESSWIRE / August 7, 2018 / Premier Biomedical, Inc (OTCQB: BIEI) a research based publicly traded biomedical company has signed a sales representative agreement with 4 Your Pain, LLC, a newly formed company whose members have extensive experience in selling medical products to the U.S. Department of Defense and other governmental agencies. The group also has experience and connections in selling to long term care facilities, which Premier Biomedical has targeted for its topical pain relief products. 4 Your Pain's executive team released a statement saying that, "We are excited to partner with Premier Biomedical in getting their pain relief products out to the individuals in need of relief from pain they have to deal with on a daily basis.

  • ACCESSWIRE17 days ago

    Premier Biomedical, Inc. Uplifted to OTCQB

    BIEI Trading on OTCQB Effective July 27, 2018 JACKSON CENTER, PA / ACCESSWIRE / July 30, 2018 / Premier Biomedical, Inc. (OTCQB: BIEI ) a research based publicly traded biomedical company announced that ...

  • GlobeNewswire29 days ago

    William Hartman, CEO of Premier Biomedical, Returns to Uptick Newswire’s “Stock Day” Podcast

    William Hartman, CEO of Premier Biomedical Inc. (OTC PINK:BIEI) ("the Company") joined Everett Jolly on Uptick Newswire’s “Stock Day” podcast. Premier Biomedical currently consists of two groups: The Biologics Group deals fundamentally with the treatment of disease, both extra-corporeally and via immunotherapy, while the second group, PainReliefMeds.Com, has developed a series of hemp oil CBD topical pain relief products (www.painreliefmeds.com).

  • ACCESSWIRElast month

    Premier Biomedical, Inc. Ceo Letter - July, 2018

    As we moved further into our new role, we realized that we would be a far stronger company if we were to represent our multi-faceted technologies as potentially independent business units. While we are continuing to develop a revenue-producing hemp oil CBD business, we are continuing to develop intellectual property based on our core extracorporeal patented technology.

  • ACCESSWIRE2 months ago

    Premier Biomedical, Inc. Effects Reverse Split

    FINRA Approves BIEI 250:1 Reverse Stock Split Effective June 27, 2018 JACKSON CENTER, PA / ACCESSWIRE / June 27, 2018 / Premier Biomedical, Inc. (OTC PINK: BIEI ) a research-based publicly traded biomedical ...

  • ACCESSWIRE2 months ago

    MoneyTV with Donald Baillargeon, 6/8

    LOS ANGELES, CA / ACCESSWIRE / June 8, 2018 / CBD-based pain relief, bitcoin trading academy, 3D medical imaging, electronic payments, the power of THEY; this week on MoneyTV with Donald Baillargeon. MoneyTV ...

  • GlobeNewswire2 months ago

    Uptick Newswire Welcomes William Hartman, CEO of Premier Biomedical, Inc. Back on to the “Stock Day” Podcast

    William Hartman, CEO of Premier Biomedical, Inc. (OTC Pink:BIEI) (“the Company”) was recently interviewed by Marcus Heatherly on Uptick Newswire’s “Stock Day” podcast. Premier Biomedical, Inc. has evolved since its inception in 2010. The company first went public in 2012, and in 2013 the leadership team signed a Cooperative Research and Development Agreement with the Department of Defense to develop a treatment for PTSD together with the University of Texas at El Paso.

  • ACCESSWIRE2 months ago

    Premier Biomedical's CEO, William A. Hartman, Visits Uptick Newswire's "Stock Day" with Marcus Heatherly

    JACKSON CENTER, PA / ACCESSWIRE / June 4, 2018 / Premier Biomedical, Inc. (OTC PINK: BIEI) President & CEO, William A. Hartman was recently interviewed by Marcus Heatherly on Uptick Newswire's "Stock Day" podcast. Premier Biomedical, Inc. has evolved since its inception in 2010. The company first went public in 2012, and in 2013 the leadership team signed a Cooperative Research And Development Agreement with the Department of Defense to develop a treatment for PTSD together with the University of Texas at El Paso.

  • ACCESSWIRE3 months ago

    MoneyTV with Donald Baillargeon, 5/25

    LOS ANGELES, CA / ACCESSWIRE / May 25, 2018 / Spirits industry, CBD, cryptocurrrency, cannabis, Swamp-Gate; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally syndicated television ...

  • ACCESSWIRE3 months ago

    MoneyTV with Donald Baillargeon, 5/18

    LOS ANGELES, CA / ACCESSWIRE / May 18, 2018 / Legal sports betting, pain relief, cryptocurrency, blockchain, CBD; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally syndicated ...

  • ACCESSWIRE4 months ago

    Premier Biomedical, Inc. CEO Letter - April 2018

    It has been a very busy and eventful quarter for Premier Biomedical. The problem for the company's position was the issued and outstanding shares (those in circulation) represented approximately 70% of the authorized shares level. In order to ensure a beneficial split for our shareholders and the company, we instituted actions to elevate the resultant stock price to a level in the range of $0.50 - $1.00, significantly reducing our outstanding shares to approximately 3 million shares while maintaining the authorized number of shares at 1 billion shares.

  • ACCESSWIRE4 months ago

    MoneyTV with Donald Baillargeon, 4/13

    LOS ANGELES, CA / ACCESSWIRE / April 13, 2018 / Pain relief, cancer treatment, blockchain and cryptocurrency, water cleanup, cannabis business, organic teas, US/China trade war; this week on MoneyTV with ...

  • ACCESSWIRE5 months ago

    ICYMI - Premier Biomedical CEO Interviewed on MoneyTV

    In Case You Missed It - Mr. Hartman Recaps the Company's History and Plans for the Future JACKSON CENTER, PA / ACCESSWIRE / March 29, 2018 / Premier Biomedical, Inc . (OTC PINK: BIEI ) President and CEO, ...

  • ACCESSWIRE5 months ago

    MoneyTV with Donald Baillargeon, 3/23

    LOS ANGELES, CA / ACCESSWIRE / March 23, 2018 / Pain relief, medical imaging, water cleanup, cannabis business, solar and roofing, cloud, blockchain, Facebook; this week on MoneyTV with Donald Baillargeon. ...

  • ACCESSWIRE5 months ago

    MoneyTV with Donald Baillargeon, 3/9

    LOS ANGELES, CA / ACCESSWIRE / March 9, 2018 / Blockchain, water cleanup, cannabis business, Chinese investors, cancer treatment, medical imaging; this week on MoneyTV with Donald Baillargeon. MoneyTV ...

  • ACCESSWIRE5 months ago

    MoneyTV with Donald Baillargeon, 3/2

    LOS ANGELES, CA / ACCESSWIRE / March 2, 2018 / CBD oil, the blockchain, water cleanup, solar and roofing, cannabis business, Chinese investors, who want the POTUS job; this week on MoneyTV with Donald ...